Cochrane · systematic review · CD010696
Betahistine for symptoms of vertigo
Murdin, L, Hussain, K, Schilder, AGM · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library
ENTAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
2
No studies
2
Included studies
NR
No studies 2 · 50%Ungraded 0 · 0%Very low 0 · 0%Low 2 · 50%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Betahistine versus placebo for symptoms of vertigo
Population: patients with symptoms of vertigo
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Benefits Betahistine vs placebo | no estimate extracted | NR | No studies |
Proportion of patients with improvement according to global judgement of patient subgrouped by diagnosis№ of participants: 606(11 RCTs) Betahistine vs placebo | RR 1.3 [1.05, 1.6] | NR | Low Downgraded: inconsistency |
Harms Betahistine vs placebo | no estimate extracted | NR | No studies |
Proportion of patients with adverse effects№ of participants: 819(12 RCTs) Betahistine vs placebo | RR 1.03 [0.76, 1.4] | NR | Low Downgraded: inconsistency |